SKYE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Skye Bioscience Inc (SKYE) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock lacks positive catalysts, has weak technical indicators, and no significant trading signals. Additionally, the financial performance shows improvement in net income and EPS but remains negative overall. The absence of recent news or analyst ratings further limits the case for immediate investment.
The technical indicators for SKYE are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 34.974, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.631 and resistance at 0.717.
The company's net income and EPS have improved YoY, with net income up 48.18% and EPS up 50.00%.
No significant trading trends from hedge funds or insiders. The stock has a 70% chance of declining by 4.09% in the next day. No recent news, analyst ratings, or congress trading data to support a positive outlook.
In 2025/Q4, revenue remained at 0 with no growth. Net income improved YoY to -14,441,963 (48.18% increase), and EPS improved to -0.36 (50% increase). Gross margin remains at 0.
No recent analyst ratings or price target changes available.
